Wugen

Drug Discovery · Saint Louis, MO · Founded 2018 · Privately Held (backing)

Developer of off-the-shelf cell therapy technology designed to treat hematologic and solid tumor cancers. Wugen is based in Saint Louis, MO and was founded in 2018. It is valued at about $215 million as of Oct 2026, set by institutional fund marks, down 12% since its later-stage round in Aug 2025. It has raised $323 million across 2 recorded rounds; the latest was an $115 million Series C in Aug 2025.

PMV mark · valuation
$214.5M
Oct 2026
Since last round
-12%
Aug 2025
Total raised
$323.0M
Last round
Later Stage VC (Series C)
Aug 2025
How much has Wugen raised?
$323.0Macross 2 recorded rounds · Dec 2022 – Aug 2025

Most recently, Wugen raised $115.0M in its Later Stage VC (Series C) (Aug 2025).

Free account
More of Wugen with a free account
  • ·The complete investor list: 13 names
  • ·Watch Wugen: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Wugen round by round

2 rounds
Aug 2025Later Stage VC (Series C)$115.0M▮
+ 1 more investors · free account
Dec 2022Early Stage VC (Series B)$172.0M▮
+ 1 more investors · free account

How much has Wugen raised?

Wugen has raised $323 million across 2 recorded rounds since 2022. The largest was a $172 million Series B in Dec 2022; the most recent was an $115 million Series C in Aug 2025.

Wugen investors

13 investors are on record for Wugen, including Fidelity Management & Research Company, Alexandria Venture Investments, Alpha Wave Global and Sands Capital. By type, the record holds 2 venture capital firms, 2 growth equity firms and 1 asset manager. The Series C in Aug 2025 drew 4 investors.

For fundraisers
Raising for a company like Wugen?

13 investors have backed Wugen — start your target list with the firms already writing checks in drug discovery.

See all 13 investors →

Frequently asked about Wugen

How much has Wugen raised?
Wugen has raised $323.0M in total across 2 recorded funding rounds.
When was Wugen's last funding round?
Wugen's most recent recorded round was Later Stage VC (Series C) in Aug 2025, raising $115.0M.